跳至主要内容
临床试验/EUCTR2017-004737-85-NL
EUCTR2017-004737-85-NL进行中(未招募)1 期

Alkaline Phosphatase to prevent ischemia reperfusion injury in living kidney transplantation - APhIRI

Amsterdam UMC, location VUmc0 个研究点目标入组 40 人开始时间: 2020年11月25日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • -Recipients of a living donor kidney
  • -First organ transplanation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • -Second or subsequent organ transplantation
  • -Strict vegetarians or veganists. These individuals have higher potential risk to an allergic reaction to the infused bovine protein.
  • -History of allergy to bovine proteins
  • -Not standard immunosuppression at time of transplantation

研究者

发起方
Amsterdam UMC, location VUmc

相似试验

Alkaline Phosphatase to prevent ischemia reperfusion... | 临床试验